Company: Artios Pharma
Job title: Head of Biology
Helen has 20 years’ experience in oncology research, the majority within the DNA damage response field. As Head of Biology at Artios Pharma, she leads a large team supporting the drug discovery process from target validation, cell assay development through to identifying and validating patient selection hypotheses. Artios’ lead programme is centred on Pol however there is an emerging portfolio of novel DDR targets at earlier stages of discovery.
Before moving into the biotechnology sector (including KuDOS and MISSION Therapeutics), Helen gained her PhD from the University of Glasgow then went on to post-doctoral training at the Beatson Institute for Cancer Research and subsequently University of Cambridge.
Discussing the Potential of Pol Theta 1:15 pm
day: Day Two